Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 2
1974 1
1975 2
1976 2
1977 2
1978 2
1979 1
1982 1
1984 1
1985 1
1990 3
1991 1
1992 1
1993 1
1994 1
1995 1
1996 2
1997 1
1998 3
1999 2
2000 2
2001 2
2002 9
2003 2
2004 2
2005 3
2006 3
2007 2
2008 7
2009 5
2010 8
2011 4
2012 7
2013 14
2014 11
2015 7
2016 15
2017 12
2018 18
2019 12
2020 19
2021 19
2022 22
2023 16
2024 8
2025 13
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
mRNA-based immunotherapy platform targeting endometrial cancer.
Freyberg M, Dierks M, Nass N, George C, Geffken M, Ignatov A, Kalinski T, Ignatova Z. Freyberg M, et al. Among authors: ignatov a. J Transl Med. 2025 Dec 5;24(1):82. doi: 10.1186/s12967-025-07497-w. J Transl Med. 2025. PMID: 41345672 Free PMC article.
Xanthomonas Phage PBR31: Classifying the Unclassifiable.
Tarakanov RI, Evseev PV, Vo HTN, Troshin KS, Gutnik DI, Ignatov AN, Toshchakov SV, Miroshnikov KA, Jafarov IH, Dzhalilov FS. Tarakanov RI, et al. Among authors: ignatov an. Viruses. 2024 Mar 6;16(3):406. doi: 10.3390/v16030406. Viruses. 2024. PMID: 38543771 Free PMC article.
Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, Schochter F, Gaß P, Rohner A, Canzler U, Becker S, Bommert M, Bauerschlag D, Denecke A, Hanker L, Runnebaum I, Forner DM, Klar M, Schwab R, Koepke M, Kalder M, Hantschmann P, Ratiu D, Denschlag D, Schroeder W, Tuschy B, Baumann K, Mustea A, Soergel P, Bronger H, Bauerschmitz G, Kosse J, Koch MC, Ignatov A, Sehouli J, Dannecker C, Schmalfeldt B, Mahner S, Woelber L. Jaeger A, et al. Among authors: ignatov a. Gynecol Oncol. 2025 Sep;200:8-13. doi: 10.1016/j.ygyno.2025.07.003. Epub 2025 Jul 16. Gynecol Oncol. 2025. PMID: 40669125
Tailed Lytic Bacteriophages of Soft Rot Pectobacteriaceae.
Miroshnikov KA, Evseev PV, Lukianova AA, Ignatov AN. Miroshnikov KA, et al. Among authors: ignatov an. Microorganisms. 2021 Aug 26;9(9):1819. doi: 10.3390/microorganisms9091819. Microorganisms. 2021. PMID: 34576713 Free PMC article. Review.
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.
Concin N, Braicu I, Combe P, Berger R, Ray-Coquard I, Joly F, Harter P, Canzler U, Selle F, Mahner S, Ignatov A, Sehouli J, Pujade-Lauraine E, Zeimet AG, Schmitt WD, Van Nieuwenhuysen E, Vanderstichele A, Dobbelstein M, Kramer D, Ulmer H, Zeillinger R, Obermayr E, Heinzl N, Marth C, Moll UM, Vergote I. Concin N, et al. Among authors: ignatov a. Clin Cancer Res. 2025 Aug 1;31(15):3160-3174. doi: 10.1158/1078-0432.CCR-24-3705. Clin Cancer Res. 2025. PMID: 40435111 Clinical Trial.
Loss of HER2 after HER2-targeted treatment.
Ignatov T, Gorbunow F, Eggemann H, Ortmann O, Ignatov A. Ignatov T, et al. Among authors: ignatov a. Breast Cancer Res Treat. 2019 Jun;175(2):401-408. doi: 10.1007/s10549-019-05173-4. Epub 2019 Feb 26. Breast Cancer Res Treat. 2019. PMID: 30806922 Clinical Trial.
259 results